Aguilar-Luis MA, Valle-Mendoza JD, Tarazona-Castro. Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024-2026). IJID Reg. 2026 Sep 1;21:100993
Objectives: Continuous genetic drift in the hemagglutinin gene of influenza A(H3N2) viruses compromises the reliability of standard molecular diagnostics, resulting in target dropouts and epidemiological surveillance gaps. This study evaluated the clinical performance of the World Health Organization (WHO)-recommended (2024) real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR) sets against emerging Peruvian A(H3N2) subclades J.2 and K, and developed an optimized dual-target multiplex assay to restore diagnostic sensitivity.
Methods: Genomic sequencing was used to identify mutational profiles in circulating Peruvian A(H3N2) subclades J.2 and K. Standard WHO (2024) oligonucleotides were tested against 20 A(H3N2)-confirmed clinical samples. The dual-target multiplex RT-qPCR assay was then redesigned with targeted bioinformatic modifications and validated.
Results: Genomic analysis identified critical oligonucleotide mismatches in both subclades. Consequently, the standard WHO assay failed to detect the virus in any tested isolate. The optimized multiplex assay successfully restored amplification in all 20 sequencing-confirmed A(H3N2) viruses. It demonstrated high analytical concordance (Pearson´s r = 0.70, P < 0.001) between the two targets without competitive inhibition. Furthermore, both the J.2 and the highly mutated K subclades were amplified with equivalent diagnostic performance.
Conclusion: The optimized dual-target RT-qPCR assay successfully overcomes the diagnostic failure of standard probes, providing a reliable, fail-safe mechanism for detecting currently circulating H3N2 variants. These findings emphasize the necessity of routine genomic audits to maintain current molecular protocols designed for detection.
Methods: Genomic sequencing was used to identify mutational profiles in circulating Peruvian A(H3N2) subclades J.2 and K. Standard WHO (2024) oligonucleotides were tested against 20 A(H3N2)-confirmed clinical samples. The dual-target multiplex RT-qPCR assay was then redesigned with targeted bioinformatic modifications and validated.
Results: Genomic analysis identified critical oligonucleotide mismatches in both subclades. Consequently, the standard WHO assay failed to detect the virus in any tested isolate. The optimized multiplex assay successfully restored amplification in all 20 sequencing-confirmed A(H3N2) viruses. It demonstrated high analytical concordance (Pearson´s r = 0.70, P < 0.001) between the two targets without competitive inhibition. Furthermore, both the J.2 and the highly mutated K subclades were amplified with equivalent diagnostic performance.
Conclusion: The optimized dual-target RT-qPCR assay successfully overcomes the diagnostic failure of standard probes, providing a reliable, fail-safe mechanism for detecting currently circulating H3N2 variants. These findings emphasize the necessity of routine genomic audits to maintain current molecular protocols designed for detection.
See Also:
Latest articles in those days:
- Weekly US Influenza Surveillance Report: Key Updates for Week 45, ending November 14, 2026 11 hours ago
- Anatomical Compartmentalization in Chickens Drives Divergent H9N2 Influenza Evolution Toward Human Receptor Binding and Immune Escape 1 days ago
- Epidemiologic Variability and Clinical Severity Across 11 Influenza Seasons in Children 2 days ago
- Molecular Epidemiology of Clade 2.3.4.4b H5N1 High-Pathogenicity Avian Influenza in South Africa, 2025-2026 2 days ago
- Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin 2 days ago
[Go Top] [Close Window]


